Literature DB >> 6431004

Intracellular processing of membrane and secreted immunoglobulin delta-chains.

Y Argon, C Milstein.   

Abstract

Membrane-bound and secreted immunoglobulin delta-chains are synthesized by the mouse hybridoma B1-8 delta.1 as two primary translation products (45,000 and 42,000, respectively) and are converted into three N-glycosylated forms. In addition to N-glycosylation, another modification, reflected in a size increase of 2000 to 3000, occurs within 8 min of synthesis and may be O-glycosylation. After these initial modifications, the N-linked carbohydrates of all three forms are partially trimmed, apparently in the endoplasmic reticulum. The secreted delta-chains acquire galactose and sialic acids less than 10 min before they are secreted. Monensin and CCCP, which are potent inhibitors of IgD secretion, inhibit the terminal glycosylation but not the other modifications of delta-chains. CCCP blocks the intracellular transport of IgD at an earlier stage of trimming than monensin. Within 10 min of the removal of CCCP, some of the accumulated IgD is terminally glycosylated and secreted. Membrane IgD is processed similarly to secreted IgD up to the stage blocked by CCCP. These observations suggest that final trimming and terminal glycosylation of IgD occurs in the Golgi complex, and that the other modifications occur in pre-Golgi compartments, where secreted IgD spends most of its transit time. We suggest that the rate-limiting step in the intracellular transport of both types of IgD is the passage from the ER to the Golgi complex.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6431004

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  A single amino acid substitution in the variable region of the light chain specifically blocks immunoglobulin secretion.

Authors:  J L Dul; Y Argon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Detection of gene targeting by co-conversion of a single nucleotide change during replacement recombination at the immunoglobulin mu heavy chain locus.

Authors:  A J Smith; B Kalogerakis
Journal:  Nucleic Acids Res       Date:  1991-12       Impact factor: 16.971

3.  Two proteins targeted to the same lytic granule compartment undergo very different posttranslational processing.

Authors:  J K Burkhardt; S Hester; Y Argon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  Specificity of the murine IgD receptor on T cells is for N-linked glycans on IgD molecules.

Authors:  A R Amin; S M Tamma; J D Oppenheim; F D Finkelman; C Kieda; R F Coico; G J Thorbecke
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

5.  Regulation of immunoglobulin D synthesis in murine neonatal B lymphocytes.

Authors:  D Yuan
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

6.  Expression of intracisternal A-type particles is increased when a B-cell lymphoma differentiates into an immunoglobulin-secreting cell.

Authors:  D L Wiest; J K Burkhardt; A M Stockdale; Y Argon
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

7.  Membrane biogenesis during B cell differentiation: most endoplasmic reticulum proteins are expressed coordinately.

Authors:  D L Wiest; J K Burkhardt; S Hester; M Hortsch; D I Meyer; Y Argon
Journal:  J Cell Biol       Date:  1990-05       Impact factor: 10.539

8.  Mitosis and inhibition of intracellular transport stimulate palmitoylation of a 62-kD protein.

Authors:  D I Mundy; G Warren
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

9.  Regulation of membrane IgM expression in secretory B cells: translational and post-translational events.

Authors:  R Sitia; M S Neuberger; C Milstein
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

10.  Quality control of ER synthesized proteins: an exposed thiol group as a three-way switch mediating assembly, retention and degradation.

Authors:  A M Fra; C Fagioli; D Finazzi; R Sitia; C M Alberini
Journal:  EMBO J       Date:  1993-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.